跳至主要内容
临床试验/NCT01991925
NCT01991925撤回不适用

Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
evaluation of quality of life

研究概览

简要总结

Patients with hereditary haemochromatosis will be interviewed/questioned about their Quality of life and the delivered quality of care in the hospital.

详细描述

Patients with hereditary haemochromatosis will be interviewed/questioned about their Quality of life and the delivered quality of care in the hospital during follow-up

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • phase 1: experts in the field of haemochromatosis (hepatologists, hematologists, endocrinologists, general practitioner, nurses, ...)
  • phase 2: patients with hereditary haemochromatosis, treatment with phlebotomy since 3 months, Dutch/English speaking

排除标准

  • patients with secondary iron overload
  • phlebotomy treatment less than 3 months
  • language: no Dutch or English

结局指标

主要结局

evaluation of quality of life

时间窗: after 3 months of treatment

quality of life

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Annick Vanclooster

Nurse

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验